High-Efficacy Therapy May Reduce Relapses in Active SPMS

TUESDAY, July 13, 2021 -- High-efficacy disease-modifying therapies may reduce flare-ups in recently active secondary progressive multiple sclerosis (SPMS), but they do not appear to offer any advantage over low-efficacy therapies for slowing...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news